U.S. Markets closed

Opiant Pharmaceuticals, Inc. (OPNT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.33+0.17 (+1.86%)
At close: 4:00PM EST

9.25 -0.08 (-0.86%)
After hours: 5:23PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.85
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.70
52 Week Low 36.79
50-Day Moving Average 38.43
200-Day Moving Average 38.39

Share Statistics

Avg Vol (3 month) 361.77k
Avg Vol (10 day) 342.48k
Shares Outstanding 54.26M
Float 3.54M
% Held by Insiders 15.67%
% Held by Institutions 131.07%
Shares Short (Dec 30, 2020) 49.16k
Short Ratio (Dec 30, 2020) 40.09
Short % of Float (Dec 30, 2020) 40.22%
Short % of Shares Outstanding (Dec 30, 2020) 40.22%
Shares Short (prior month Nov 29, 2020) 411.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Dec 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -0.40%
Operating Margin (ttm)-1.80%

Management Effectiveness

Return on Assets (ttm)-0.74%
Return on Equity (ttm)-0.32%

Income Statement

Revenue (ttm)27.37M
Revenue Per Share (ttm)6.49
Quarterly Revenue Growth (yoy)-55.90%
Gross Profit (ttm)23.72M
EBITDA -369.29k
Net Income Avi to Common (ttm)-108.08k
Diluted EPS (ttm)-0.03
Quarterly Earnings Growth (yoy)-93.20%

Balance Sheet

Total Cash (mrq)31.1M
Total Cash Per Share (mrq)7.3
Total Debt (mrq)400.57k
Total Debt/Equity (mrq)1.13
Current Ratio (mrq)6.06
Book Value Per Share (mrq)8.35

Cash Flow Statement

Operating Cash Flow (ttm)6.46M
Levered Free Cash Flow (ttm)7.56M